Glaukos Corp (GKOS)
107.88
+2.87
(+2.73%)
USD |
NYSE |
May 07, 16:00
98.00
-9.88
(-9.16%)
After-Hours: 20:00
Glaukos Enterprise Value: 5.299B for May 6, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 06, 2024 | 5.299B |
| May 03, 2024 | 5.375B |
| May 02, 2024 | 5.300B |
| May 01, 2024 | 4.992B |
| April 30, 2024 | 4.846B |
| April 29, 2024 | 4.889B |
| April 26, 2024 | 5.003B |
| April 25, 2024 | 5.035B |
| April 24, 2024 | 5.076B |
| April 23, 2024 | 5.084B |
| April 22, 2024 | 4.976B |
| April 19, 2024 | 4.853B |
| April 18, 2024 | 4.785B |
| April 17, 2024 | 4.873B |
| April 16, 2024 | 4.876B |
| April 15, 2024 | 4.871B |
| April 12, 2024 | 4.940B |
| April 11, 2024 | 4.992B |
| April 10, 2024 | 5.015B |
| April 09, 2024 | 5.095B |
| April 08, 2024 | 5.061B |
| April 05, 2024 | 4.867B |
| April 04, 2024 | 4.702B |
| April 03, 2024 | 4.711B |
| April 02, 2024 | 4.471B |
| Date | Value |
|---|---|
| April 01, 2024 | 4.651B |
| March 31, 2024 | 4.710B |
| March 28, 2024 | 4.652B |
| March 27, 2024 | 4.573B |
| March 26, 2024 | 4.425B |
| March 25, 2024 | 4.376B |
| March 22, 2024 | 4.345B |
| March 21, 2024 | 4.317B |
| March 20, 2024 | 4.306B |
| March 19, 2024 | 4.322B |
| March 18, 2024 | 4.215B |
| March 15, 2024 | 4.217B |
| March 14, 2024 | 4.231B |
| March 13, 2024 | 4.321B |
| March 12, 2024 | 4.291B |
| March 11, 2024 | 4.284B |
| March 08, 2024 | 4.314B |
| March 07, 2024 | 4.386B |
| March 06, 2024 | 4.217B |
| March 05, 2024 | 4.158B |
| March 04, 2024 | 4.368B |
| March 01, 2024 | 4.381B |
| February 29, 2024 | 4.370B |
| February 28, 2024 | 4.442B |
| February 27, 2024 | 4.463B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
942.81M
Minimum
Mar 20 2020
5.375B
Maximum
May 03 2024
2.665B
Average
2.388B
Median
Sep 10 2019
Enterprise Value Benchmarks
| Boston Scientific Corp | 115.19B |
| Globus Medical Inc | 6.705B |
| PROCEPT BioRobotics Corp | 2.982B |
| Accuray Inc | 290.56M |
| Asensus Surgical Inc | 45.19M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -40.84M |
| Revenue (Quarterly) | 85.62M |
| Total Expenses (Quarterly) | 112.96M |
| EPS Diluted (Quarterly) | -0.82 |
| Gross Profit Margin (Quarterly) | 76.34% |
| Profit Margin (Quarterly) | -47.70% |
| Earnings Yield | -2.67% |
| Normalized Earnings Yield | -2.463 |